Skip to Main Content

Paper Details

Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial.
Prostate
17
2017
C, G, IFNG, IL1, IL10, IL10 haplotypes, IL10 tagSNPs, IL12, IL2, IL4, IL6, IL8, MSR1, PCPT, PSA, Prostate Cancer, RNASEL, SNPs, T, TLR4, TNFA, cancer, candidate SNPs, finasteride, immune response genes, intraprostatic inflammation, lower- and higher-grade prostate cancer, men, p40, prostate cancer, rs1800795, rs1800797, rs1800896, rs2243250, rs2430561, rs3747531, rs4073, single nucleotide polymorphisms, tagSNPs
Author NameAffiliation
Regina M SantellaMailman School of Public Health, Columbia University
Teresa L Johnson-PaisUniversity of Texas Health Science Center at San Antonio
Robin J LeachUniversity of Texas Health Science Center at San Antonio
Jianfeng XuNorthShore University Health System
Ian M ThompsonUniversity of Texas Health Science Center at San Antonio
Marshall Scott LuciaUniversity of Colorado Denver School of Medicine
Scott M LippmanMoores Cancer Center, University of California San Diego
William B IsaacsJames Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine
William B IsaacsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
  • 1 - 9

Datasets

Release 1.2